Evidence map›Paper›PMID 40738627›Full record

ArticleBMJ open2025

Cross-sectoral synergy governance programme for antimicrobial resistance control in China using a 'One Health' approach: study protocol for a mixed-methods study.

Zhixin Fan, Jia Yin, Zhibin Zhang, Xiaolin Wei, Ding Yang, Qiang Sun

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhixin FanDepartment of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.ORCID http://orcid.org/0009-0005-0635-113X
Jia YinDepartment of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
Zhibin ZhangInstitute of Computing Technology, Chinese Academy of Sciences, Beijing, China.
Xiaolin WeiDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-3076-2650
Ding YangDepartment of Global Public Health Karolinska Institutet, Stockholm, Sweden.
Qiang SunDepartment of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China qiangs@sdu.edu.cn.ORCID http://orcid.org/0000-0003-3056-2322

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAntimicrobial resistance (AMR) is a critical global public health concern, particularly acute in rural China. Counties, which cover extensive rural regions, face major challenges in AMR governance and thus require priority attention. Yet, AMR governance efforts across sectors are fragmented, with notable gaps in translating policy objectives into sustainable, practical governance measures. This programme will entail a series of studies focusing on county-level cross-sectoral synergy governance for AMR, aiming to identify optimal synergy governance strategies to curb AMR. METHODS AND ANALYSIS: The study comprises three phases: (1) understanding and exploring the state of cross-sectoral synergy governance and its internal mechanisms; (2) empirically evaluating AMR synergy governance capability using a developed evaluation indicator tool; and (3) identifying optimal AMR synergy governance strategies through a simulation and prediction model. Phase I involves conducting a content analysis of policy documents and semistructured interviews to understand and explore the state of cross-sectoral synergy governance and internal mechanisms. An evaluation indicator tool for AMR synergy governance capability will be developed through a two-round modified Delphi survey, hierarchical analysis process and percentage weighting method, with a typical case analysis being used for empirical evaluation in phase II. Phase III entails developing a simulation and prediction model using a series of artificial intelligence technologies, such as distributed Scrapy crawler technology, large language models, generative adversarial networks and deep multilayer models, all aimed at identifying optimal AMR synergy governance strategies. ETHICS AND DISSEMINATION: This study was approved by the ethics committee of the Centre for Health Management and Policy Research, Shandong University (No. ECSHCMSDU20240904). The results of the studies will be submitted for publication in peer-reviewed journals, presented at national and international academic conferences.

Indexed as

Anti-Bacterial AgentsDrug Resistance, MicrobialOne HealthChinaHealth PolicyHumansResearch DesignAnti-Bacterial Agentsantimicrobial resistanceChinaone healthsimulation predictionsynergy governance

Identifiers

PMID40738627
PMCPMC12315018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.